摘要
目的介绍转运蛋白在药物传递中的重要作用。方法根据文献对转运蛋白在药物传递中的重要作用进行综述。结果转运蛋白能有效地参与药物的肠吸收、分布和排泄等过程,以其为靶点可大大提高药物传递的效率,减少不良反应的发生。结论可深入地解析药物体内动态和更有效地调控药物体内行为,从而设计出安全、有效的药物及其传递系统。
出处
《中国药学杂志》
CAS
CSCD
北大核心
2007年第3期164-168,共5页
Chinese Pharmaceutical Journal
参考文献25
-
1孙进,孙勇兵,何仲贵.转运蛋白在药物肝胆转运中的重要作用[J].药学学报,2005,40(8):680-685. 被引量:17
-
2高坤,孙进,何仲贵.肠道转运蛋白在药物吸收中的重要作用[J].药学学报,2006,41(2):97-102. 被引量:17
-
3TAMAI I,NAKANISHI T,NAKAHARA H,et al.Improvement of L-Dopa absorption by dipeptidyl derivation,utilizing peptide transporter Pept1[J].J Pharm Sci,1998,87(12):1542-1546.
-
4HU M,SUBRAMANIAN P,MOSBERG H I,et al.Use of the peptide carrier system to improve the intestinal absorption of L-α-methyldopa:carrier kinetics,intestinal permeabilities,and in vitro hydrolysis of dipeptidyl derivatives of L-α-methyldopa[J].Pharm Res,1989,6(1):66-70.
-
5HAN H.5'-Amino acid esters of antiviral nucleosides,Acyclovir,and AZT are absorbed by the intestinal PEPTl peptide transporter[J].Pharm Res,1998,15(8):1154-1159.
-
6CVETKOVIC M,LEAKE B,FROMM M F,et al.OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine[J].Drug Metab Dispos,1999,27(8):866~871.
-
7HISANG B,ZHU Y,WANG Z,et al.A novel human organic anion transporting polypeptide and identification of rat and human hydroxymethylglutaryl-CoA reductase inhibitors transporters[J].J Biol Chem,1999,274:37161-37168.
-
8DRESCHER S,GLAESER H,MURDTER T,et al.P-glycoprotein-mediated intestinal and biliary digoxin transport in humans[J].Clin Pharmacol Ther,2003,73(3):223-231.
-
9SUN J,HE Z,CHENG G,et al.Multidrug resistance P-glycoprotein:the crucial significances in drug disposition and interaction[J].Med Sci Monitor,2004,10(1):5-14.
-
10GOTOH Y,SUZUKI H,KINOSHITA S,et al.Involvement of an organic anion transporter (canalicular multispecific organic anion transporter/mulfidrug resistance-associated protein 2) in gastrointestinal secretion of glutathione conjugates in rats[J].J Pharmacol Exp Ther,2000 292(1):433-439.
二级参考文献60
-
1Jonker JW, Wagenaar E, Moi CA, et al. Reduced hepatic uptake and intestinal excretion of organic cations in mice with a targeted disruption of the organic cation transporter 1 ( Octl [ Slc22a1) gene[J]. Mol Cell Biol, 2001,21(16) : 5471 - 5477.
-
2Wang DS, Jonker JW, Kato Y, et al. Involvement of organic cation transporter 1 in hepatic and intestinal distribution of metformin [ J ]. J Pharmacol Exp Ther,2002,302(2) :510 - 515.
-
3Tamai l, Yabuuchi H, Nezu Y, et al. Cloning and characterization of a novel human pH-dependent organic cation transporter, OCTN1[J]. FEBS Lett, 1997,419(1) :107 -111.
-
4Flens MJ, Zaman GJ, Van der Valk P, et al. Tissue distribution of the muhidrug resistance protein[J]. Am J Pathol, 1996,148(4) : 1237 - 1247.
-
5Ogawa K, Suzuki H, Hirohashi T, et al. Characterization of inducible nature of Mrp3 in rat liver[J]. Am J Physiol, 2000,295 ( 3 ) : G438 - G446.
-
6Konig J, Rost D, Cui Y, et al. Characterization of the human muhidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane[ J ].Hepatology, 1999,29(4) :1156 - 1163.
-
7Hirohashi T, Suzuki H, Takikawa H, et al. ATP-dependent transport of bile salts by rat muhidrug resistance-associated protein ( Mrp3 ) [ J ]. J Biol Chem,2000,275 (4) : 2905 - 2910.
-
8Thompson lL, Jansen PLM. Genetic defects in hepatocanalicular transport[ J ]. Semin Liver Dis, 2000,20(3) :365 -372.
-
9Funk C, Ponelle C, Scheuermann G, et al. Cholestatic potential of troglitazone as a possible factor contributing to troglitazone-induced hepatotoxicity, in vivo and in vitro interaction at the canalicular bile salt export pump(Bsep) in the rat [J]. Mol Pharmacol, 2001,59(3):627 - 635.
-
10Yamazaki M, Akiyama S, Nitnuma K, et al. Biliary excretion of pravastafin in rats: contribution of the excretion pathway mediated by canalicular mulfispecific organic anion transporter[J]. Drug Metab Dispos, 1997,25(10) :1123 - 1129.
共引文献28
-
1曾宪成,马璟.动物生理节律影响药物代谢过程的分子基础及其调节机制的研究进展[J].中国药理学与毒理学杂志,2010,24(4):317-320. 被引量:1
-
2陈建英.口服药物吸收中的生物药剂学性质[J].中国药物经济学,2013,8(S2):19-20. 被引量:1
-
3刘晓磊,唐靖,宋娟,何娟,徐萍,彭文兴.川芎嗪对大鼠灌服环孢素A药代动力学的影响[J].药学学报,2006,41(9):882-887. 被引量:16
-
4李洁,王艳娇,孙进,何仲贵.转运蛋白在药物肾脏转运中的重要作用[J].中国临床药理学杂志,2006,22(4):303-306.
-
5孙勇兵,孙进,何仲贵.小肠寡肽转运蛋白及其在提高药物口服吸收中的应用[J].中国新药与临床杂志,2006,25(10):776-782. 被引量:5
-
6孙进,赵焰平,郝秀华,何仲贵.多药耐药相关蛋白2:在肠道药物处置中的重要作用[J].中国新药与临床杂志,2006,25(10):792-797. 被引量:2
-
7高坤,孙进,何仲贵.口服药物吸收中的生物药剂学性质[J].沈阳药科大学学报,2007,24(3):186-192. 被引量:22
-
8曹燚,韩凤梅,陈勇.小檗碱与人血清白蛋白结合的电喷雾离子阱质谱研究[J].分析科学学报,2007,23(4):389-392. 被引量:2
-
9田艳燕,葛兰,段相林,高志清,常彦忠.番茄红素脂质体的体外释放及大鼠体内药代动力学和抗氧化功能[J].药学学报,2007,42(10):1107-1111. 被引量:10
-
10王霄旸,李多伟.转运蛋白与药物代谢动力学、多药耐药关系的研究进展[J].西北药学杂志,2008,23(4):248-250.
同被引文献32
-
1孙进,赵焰平,郝秀华,何仲贵.多药耐药相关蛋白2:在肠道药物处置中的重要作用[J].中国新药与临床杂志,2006,25(10):792-797. 被引量:2
-
2Endres C J, Hsiao P, Chung F S, et al. The role of transport ers in drug interactions[J]. Eur J Pharm Sci, 2006, 27 (5): 501-517.
-
3Szakacs G, Varadi A, Ozvegy-Laezka C, et al. The role of ABC transporters in drug absorption, distribution, metabolism, excretion and toxicity (ADME-Tox)[J]. Drug Discov Today, 2008, 13(9 10): 379-393.
-
4Lin JH. Drug-drug interaction mediated by inhibition and in duction of P glycoprotein[J]. Adv Drug Deliv Rev, 2003, 55 (1): 53-81.
-
5Vallakati A, Chandra PA, Pednekar M, et al. Droncdarone Induced Digoxin Toxicity: New Drug, New Interactions[J]. Am J Ther, 2011.
-
6Friedrich C, Ring A, Brand T, et al. Evaluation of the pharmacokinetic interaction after multiple oral doses of linagliptin and digoxin in healthy volunteers[J]. Eur J Drug Metab Phar macokinet, 2011, 36(1) : 17-24.
-
7Shoal SE, Ohzone Y, Ninomiya S, et al. In vitro P-glycopro tein interactions and steady-state pharmacokinetie interactions between tolvaptan and digoxin in healthy subjects[J]. J Clin Pharmaeol, 2011, 51 (5) : 761-769.
-
8Aylin Arici M, Kilinc E, Demir O, et al. Interactions between Verapamil and Digoxin in Langendorff Perfused Rat Hearts:The Role of Inhibition of P-glycoprotein in the Heart[J]. Basic Clin Pharmaeol Toxieol,2010, 107(5): 847-852.
-
9Schmitt C, Kaeser B, Riek M, et al. Effect of saquinavir/ ritonavir on P-glycoprotein activity in healthy volunteers using digoxin as a probe[J]. Int J Clin Pharmacol Ther, 2010, 48 (3): 192-199.
-
10Oga E F, Sekine S, Shitara Y, et al. Potential P glycoprotein mediated drug-drug interactions of antimalarial agents in Caco-2 cells[J]. Am J Trop Med Hyg, 2012, 87(1): 64-69.
二级引证文献10
-
1张建萍.临床常见的草药与化学药相互作用分析[J].河南医学研究,2014,23(7):159-160. 被引量:1
-
2张波,闫春雷,邢晓敏,苏乐群,许冬梅,黄欣.慢性肾功能衰竭对P-糖蛋白及其介导的药物转运的影响[J].中国医院药学杂志,2015,35(5):467-470.
-
3张巧玲,雷国锋.中西药物联合应用治疗肺炎及相互作用临床分析[J].北方药学,2015,12(8):97-98.
-
4周利婷,宋燕青,曲晓宇,张四喜,武新安.甘草酸单铵保护利福平致大鼠肝损伤的机制初探[J].中国医院药学杂志,2015,35(18):1650-1654. 被引量:4
-
5王春梅,褚燕琦,张建,李建新,贾建国,谷涌泉.浅谈带教重症监护室实习临床药师的几点体会[J].药学服务与研究,2015,15(4):303-305. 被引量:1
-
6蒲强红,吕秋菊,李秀英,钟怡,李凡敏.药物转运体OAT2研究进展[J].中国医院药学杂志,2016,36(4):331-335. 被引量:1
-
7罗冰峰,尹强,王荣,李文斌,鹿辉,贾正平.缺氧对大鼠药物转运体MDR1、MRP2表达的影响[J].南方医科大学学报,2016,36(9):1169-1174. 被引量:8
-
8周利婷,曲晓宇,陶娌娜,牛俊奇,丁艳华,宋燕青.雷公藤甲素致小鼠肝损伤对转运体Mrp2和Oatp2的影响[J].中国医院药学杂志,2016,36(21):1844-1847. 被引量:6
-
9杨世磊,刘克辛.药物转运体表观遗传调控机制的研究进展[J].药物评价研究,2017,40(9):1229-1234. 被引量:3
-
10李靖,贺亚都,王爱民,李勇军,郑林,刘亭.骨康胶囊对大鼠肝脏药物转运体蛋白表达的影响[J].中成药,2021,43(11):3140-3143. 被引量:1
-
1小川芳毅,许铁男.口服头孢他美酯的体内动态[J].国外医药(抗生素分册),1994,15(4):273-274.
-
2叶礼焱.氟喹诺酮的抗菌作用及临床应用[J].浙江医学情报,1994(4):43-44.
-
3贺玉琢.钩藤中去氢毛钩藤碱及毛钩藤碱在大鼠尿液中的代谢物[J].国际中医中药杂志,2006,28(6):366-366.
-
4桥本茂一,许铁男.注射用头孢哌酮的体内动态[J].国外医药(抗生素分册),1990,11(6):445-447. 被引量:4
-
5周国川,徐鸣夏,吕丁,杨勤.2-(2,4-二氟苯基)-1-(4-烃基派嗪-1-基)-3-(1,2,4-三唑-1-基)-2-丙醇类化合物的合成及抗真菌活性[J].化学研究与应用,2003,15(4):521-523. 被引量:2
-
6刘勇,庞国勋,王学超.胆固醇吸收调控药物临床研究进展[J].河北医药,2016,38(22):3489-3491. 被引量:2
-
7王琪,刘宏,吕玲.子宫收缩的分子机制与相关调控药物的研究进展[J].中国医院药学杂志,2012,32(17):1393-1396. 被引量:13
-
8贾永明,刘志浩,刘克辛.白藜芦醇对药物转运体和代谢酶影响的研究进展[J].药学学报,2016,51(6):860-865. 被引量:3
-
9的打裕安,许铁男.头孢菌素Cefuzoname的体内动态[J].国外医药(抗生素分册),1992,13(1):30-31.
-
10董丽春,贺建昌,冯恩富,刘苗,李文锋,龚媛媛,余崇静,吕安安,李星仪,杜鹏,徐贵丽.餐时给药条件下盐酸伊伐布雷定片在健康人体的药动-药效学研究[J].中国临床药理学与治疗学,2016,21(6):667-672.